SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-334249
Filing Date
2017-11-06
Accepted
2017-11-06 16:02:08
Documents
56
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d464223d10q.htm 10-Q 770579
2 EX-31.1 d464223dex311.htm EX-31.1 6237
3 EX-31.2 d464223dex312.htm EX-31.2 6320
4 EX-32.1 d464223dex321.htm EX-32.1 4573
11 GRAPHIC g464223dsp38a.jpg GRAPHIC 92639
  Complete submission text file 0001193125-17-334249.txt   4037500

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ziop-20170930.xml EX-101.INS 561308
6 XBRL TAXONOMY EXTENSION SCHEMA ziop-20170930.xsd EX-101.SCH 44372
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20170930_cal.xml EX-101.CAL 41688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20170930_def.xml EX-101.DEF 202766
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20170930_lab.xml EX-101.LAB 376613
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20170930_pre.xml EX-101.PRE 280789
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 171179508
SIC: 2834 Pharmaceutical Preparations